Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)

Tasci, Elif SenocakOyan, BasakSonmez, OzlemMutlu, Arda UlasAtci, Muhammed MustafaSakin, AbdullahOner, Irem2024-10-292024-10-2920241471-2407https://doi.org/10.1186/s12885-024-11863-0https://hdl.handle.net/20.500.11776/14518[Abstract Not Available]en10.1186/s12885-024-11863-0info:eu-repo/semantics/openAccessComparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)Correction241N/AWOS:0011483002000022-s2.0-8518282880738262962Q1